期刊文献+

富血小板凝胶在糖尿病足溃疡治疗中的应用 被引量:6

Application of platelet-rich gel in the treatment of diabetic foot ulcer
原文传递
导出
摘要 富血小板凝胶是近年来新出现的辅助治疗糖尿病足溃疡(DFU)的方法之一.局部应用富血小板凝胶治疗DFU可有效改善DFU的难愈合性并提高溃疡愈合率,且无明显不良反应发生;也可降低截肢率,且没有增加医疗总费用.富血小板凝胶治疗DFU的作用机制可能与其中富含的生长因子、细胞因子和白细胞等有关,还可能与凝胶超微结构、溃疡中基质金属蛋白酶的变化有关. Platelet-rich gel is one of the new adjuvant therapies of diabetic foot ulcer (DFU).The topical application of platelet-rich gel is efficient in reversing the nonhealing character and improving the outcomes of DFU,with no serious adverse events.It also reduces the amputation risk of lower limbs without increasing the total medical expenditure.Platelet-rich gel is rich in growth factors,cytokines and white blood cells,which may be the underlying mechanism for its efficiency in DFU treatment;moreover,the special ultrastructure and the stimulation of matrix metalloproteinase in the ulcers may also helpful for the growth of ulcer tissue.
出处 《国际内分泌代谢杂志》 2015年第2期130-132,共3页 International Journal of Endocrinology and Metabolism
关键词 富血小板凝胶 糖尿病 糖尿病足溃疡 Platelet-rich gel Diabetes mellitus Diabetic foot ulcer
  • 相关文献

参考文献24

  • 1Won SH,Chung CY,Park MS,et al.Risk factors associated with amputation-free survival in patient with diabetic foot ulcers[J]. Yonsei Med J,2014,55(5 ) : 1373-1378.
  • 2Marfins-Mendes D, Monteiro-Soares M, Boyko EJ, et al.The independent contribution of diabetic foot ulcer on lower extremity amputation and mortality risk[J]J Diabetes Complications,2014, 28(5) :632-638.
  • 3Hicks CW,Selvarajah S,Mathioudakis N,et al.Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers[J]J Vasc Surg, 20 l d, 60(5 ):1247-1254.
  • 4Waniczek D,Kozowicz A,Muc-Wierzgofi MA,et al.Adjunct methods of the standard diabetic foot ulceration therapy[J].Evid Based Complement Ahernat Med, 2013,2013(2013 ) : 243568.
  • 5Lubkowska A, Dolegowska B,Banfi G.Growth factor content in PRP and their applicability in medicine[J].J Biol Regul Homeost Agents,2013,26(2 Suppl 1 ) :3S-22S.
  • 6Margolis D J, Kantor J, Santanna J, et al.Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers[J]. Diabetes Care,2001,24(3) :483-488.
  • 7Mehrannia M,Vaezi M,Yousefshahi FA.Platelet rich plasma for treatment of nonhealing diabetic foot ulcers: a case report[J]. Can J Diabetes, 2014,38 ( 1 ) : 5-8.
  • 8Driver VR,Hanft J,Fyling CP,et al.A prospective,randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers[J].Ostomy Wound Manage,2006, 52(6):68.
  • 9de Leon JM,Driver VR,Fylling CP,et al.The clinical relevance of treating chronic wounds with an enhanced near-physiological concentration of platelet-rich plasma gel[J].Adv Skin Wound Care, 2011,24(8) ." 357-368.
  • 10Frykberg RG,Driver VR,Carman D,et al.Chronic wounds treated with a physiologically relevant concentration of plateletrich plasma gel:a prospective ease series[J].Ostomy Wound Manage, 2010,56(6 ) : 36.

二级参考文献37

  • 1王爱红,赵湜,李强,王鹏华,严励,杜玉茗,卞茸文,王战建,毛季萍,肖正华,马学毅,林少达,陈国昌,周迎生,许樟荣.中国部分省市糖尿病足调查及医学经济学分析[J].中华内分泌代谢杂志,2005,21(6):496-499. 被引量:276
  • 2袁南兵,王椿,王艳,余婷婷,舒世清,刘敏,冉兴无.自体富血小板凝胶在糖尿病难治性皮肤溃疡中的初步应用[J].四川大学学报(医学版),2007,38(5):900-903. 被引量:52
  • 3Chen C, Schultz GS, Bloch M, et al. Molecular and mechanistic validation of delayed healing rat wounds as a model for human chronic wounds. Wound Repair Regen, 1999 ; 7(6) : 486-494.
  • 4Trengove NJ, Stacey MC, MacAuley S, et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen, 1999: 7 (6) : 442- 452.
  • 5Lobmann R, Ambrosch A, Schultz G, et al. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia, 2002 ; 45 (7) : 1011-1016.
  • 6Donahue TR, Hiatt JR, Busuttil RW. Collagenase and surgical disease. Hernia,2006:10(6) :478-485.
  • 7Mandal M, Mandal A, Das S, et al. Clinical implications of matrix metalloproteinases. Mol Cell Biochem, 2003 : 252 (1-2) :305-329.
  • 8Ladwig GP, Robson MC, Liu R, et al. Ratios of activated matrix metatloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Repair Regen,2002:10 (1) :26-37.
  • 9Mohan R, Chintala SK, Jung JC, et al. Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. J Biol Chem, 2002; 277 (3): 2065-2072.
  • 10Wall SJ, Bevan D, Thomas DW, et al. Differential expression of matrix metalloproteinases during impaired wound healing of the diabetes mouse. J Invest Dermatol, 2002 ; 119 ( 1 ) .. 91-98.

共引文献65

同被引文献71

引证文献6

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部